Ken Griffin Citadel Advisors
Ken Griffin founded Citadel, one of the world’s largest and most successful hedge funds. Starting his trading career from his Harvard dorm room at a young age, Griffin quickly developed a keen sense for markets and built Citadel into a global powerhouse with billions in assets under management. Known for his quantitative and technology-driven strategies, Griffin has also made headlines for significant philanthropic contributions, supporting causes in education, the arts, and public institutions. Over the years, he has earned recognition as one of the preeminent figures in modern finance.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
SCHW
Charles Schwab
SCHW
|
+$1.44B |
| 2 |
Invesco QQQ Trust
QQQ
|
+$1.15B |
| 3 |
GE HealthCare
GEHC
|
+$552M |
| 4 |
Danaher
DHR
|
+$447M |
| 5 |
Strategy Inc
MSTR
|
+$416M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$989M |
| 2 |
Boeing
BA
|
+$893M |
| 3 |
Bank of America
BAC
|
+$753M |
| 4 |
Arthur J. Gallagher & Co
AJG
|
+$750M |
| 5 |
Coca-Cola
KO
|
+$638M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 3.24% |
| 2 | Technology | 2.87% |
| 3 | Financials | 2.43% |
| 4 | Consumer Discretionary | 2.22% |
| 5 | Industrials | 1.75% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
6776
4D Molecular Therapeutics
FDMT
$813M
| $1.07M | ﹤0.01% |
331,211
-273,881
| -45% | -$1.29M |
|
6777
iShares International Dividend Growth ETF
IGRO
$1.3B
| $1.07M | ﹤0.01% |
14,745
+7,015
| +91% | +$497K |
|
6778
VanEck Steel ETF
SLX
$174M
| $1.07M | ﹤0.01% |
17,365
-13,227
| -43% | -$817K |
|
6779
iShares Yield Optimized Bond ETF
BYLD
$441M
| $1.07M | ﹤0.01% |
47,614
-17,328
| -27% | -$387K |
|
6780
Danaos Corp
DAC
$2.64B
| $1.07M | ﹤0.01% |
13,679
+13,579
| +13,579% | +$1.09M |
|
6781
Global Net Lease
GNL
$2.04B
| $1.07M | ﹤0.01% |
132,746
-71,294
| -35% | -$536K |
|
6782
PUT
Vishay Intertechnology
VSH
$5.14B
| $1.07M | ﹤0.01% |
67,100
-24,700
| -27% | -$423K |
|
6783
CALL
Humacyte
HUMA
$162M
| $1.07M | ﹤0.01% |
625,700
+499,800
| +397% | +$1.88M |
|
6784
CALL
Syndax Pharmaceuticals
SNDX
$1.78B
| $1.07M | ﹤0.01% |
86,800
-40,100
| -32% | -$566K |
|
6785
CALL
Capricor Therapeutics
CAPR
$411M
| $1.07M | ﹤0.01% |
112,300
+48,500
| +76% | +$673K |
|
|
TTAN
6786
PUT
ServiceTitan Inc
TTAN
$8.69B
| $1.07M | ﹤0.01% |
11,200
+7,500
| +203% | +$727K |
|
6787
PUT
Alignment Healthcare
ALHC
$2.74B
| $1.07M | ﹤0.01% |
57,200
-7,400
| -11% | -$110K |
|
6788
PIMCO 15+ Year US TIPS Index Exchange-Traded Fund
LTPZ
$772M
| $1.06M | ﹤0.01% |
19,415
-9,094
| -32% | -$486K |
|
6789
PUT
Trex
TREX
$4.86B
| $1.06M | ﹤0.01% |
18,300
-6,000
| -25% | -$390K |
|
6790
PUT
Vanguard Long-Term Corporate Bond ETF
VCLT
$8.7B
| $1.06M | ﹤0.01% |
14,000
-2,400
| -15% | -$181K |
|
6791
PUT
State Street SPDR Portfolio S&P 500 High Dividend ETF
SPYD
$7.71B
| $1.06M | ﹤0.01% |
24,000
-6,100
| -20% | -$268K |
|
|
PDCO
6792
CALL
DELISTED
Patterson Companies, Inc.
PDCO
| $1.06M | ﹤0.01% |
34,000
-90,100
| -73% | -$2.8M |
|
6793
American Century US Quality Growth ETF
QGRO
$2.01B
| $1.06M | ﹤0.01% |
11,337
-1,168
| -9% | -$119K |
|
6794
Invesco National AMT-Free Municipal Bond ETF
PZA
$4.23B
| $1.06M | ﹤0.01% |
46,053
-506,936
| -92% | -$11.9M |
|
6795
CALL
Clearfield
CLFD
$382M
| $1.06M | ﹤0.01% |
35,700
-3,600
| -9% | -$120K |
|
6796
PUT
Kimco Realty
KIM
$16.2B
| $1.06M | ﹤0.01% |
49,900
+23,000
| +86% | +$502K |
|
6797
PUT
Ascendis Pharma A/S
ASND
$16.3B
| $1.06M | ﹤0.01% |
6,800
-5,900
| -46% | -$843K |
|
6798
Macy's
M
$6.11B
| $1.06M | ﹤0.01% |
84,260
-1,605,852
| -95% | -$23.3M |
|
6799
Grupo Cibest SA
CIB
$23.1B
| $1.06M | ﹤0.01% |
26,312
+25,456
| +2,974% | +$1,000K |
|
|
LOMA
6800
PUT
Loma Negra
LOMA
$1.08B
| $1.06M | ﹤0.01% |
96,200
+29,900
| +45% | +$342K |
|
Similar funds
Ken Griffin's Q1 2025 Portfolio in Review
As of Q1 2025, Ken Griffin held 16,069 positions worth $527B, down 8.7% from $578B the previous quarter. Its ten largest holdings account for 32% of the portfolio.
Ken Griffin's Q1 2025 filing shows 1,671 new, 6,327 increased, 6,228 reduced and 1,709 closed positions. Its largest new stake was CMS Energy: 1,417,315 shares worth $106M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $989M.
By sector, the portfolio is most concentrated in Healthcare at 3.2% of assets, up from 3.1% a quarter earlier, followed by Technology and Financials.
- Ken Griffin's largest Q1 2025 buy was CMS Energy: 1,417,315 shares worth $106M.
- Ken Griffin added most to Charles Schwab in Q1 2025, an estimated $1.44B increase.
- Ken Griffin's biggest Q1 2025 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $989M.
- Ken Griffin fully exited Walmart Inc in Q1 2025, selling an estimated $462M.
- Ken Griffin's ten largest holdings make up 32% of its $527B portfolio in Q1 2025.
- Ken Griffin opened 1,671 new positions and closed 1,709 in Q1 2025.
- Ken Griffin's portfolio value fell 8.7% quarter-over-quarter to $527B.
Based on Citadel Advisors's 13F filing for Q1 2025, filed 15 May 2025.